Additive effects of the mutations in the β3-adrenergic receptor and uncoupling protein-1 genes on weight loss and weight maintenance in Finnish women

被引:66
作者
Fogelholm, M
Valve, R
Kukkonen-Harjula, K
Nenonen, A
Hakkarainen, V
Laakso, M
Uusitupa, M
机构
[1] UKK Inst Hlth Promot & Res, Tampere 33501, Finland
[2] Univ Kuopio, Dept Clin Nutr, FIN-70211 Kuopio, Finland
[3] Univ Kuopio, Dept Med, FIN-70211 Kuopio, Finland
关键词
D O I
10.1210/jc.83.12.4246
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study examined whether the Trp(64)Arg mutation in the beta(3)-adrenergic receptor (beta(3)AR) and the A-->G mutation in the uncoupling protein-1. (UCP-1) genes have associations with weight loss and subsequent weight maintenance. Seventy-seven obese (body mass index range, 29-46 kg/m(2)), clinically healthy, premenopausal women were studied. A 12-wk weight reduction by very low calorie diet (VLCD) was followed by a 40-wk weight maintenance phase. The subjects were divided into four groups according to their beta(3)AR and UCP-1 genotype: no mutation (control; n = 37), only Trp(64)Arg mutation in the beta(3)AR gene (n = 12), only A-->G mutation in the UCP-1 gene (n = 23), and both mutations (n = 5). Subjects with both mutations had a lower weight reduction during VLCD than the controls [-10.5 +/- 0.6 (+/- SEM) vs. -14.0 +/- 0.5 kg; P = 0.051, by ANOVA]. During the maintenance phase, weight in subjects with both mutations increased by 5.8 +/- 1.5 kg, but remained unchanged in the controls (- 0.5 +/- 0.8 kg; P = 0.041). The changes in weight in subjects with only one of the mutation were close to the results in the controls. Resting energy expenditure, adjusted for fat mass, fat-free mass, and maximal aerobic power, did not change differently between the groups throughout the study. The results suggest that a combination of the Trp(64)Arg mutation in the beta(3)AR and the A-->G mutation in the UCP-1 genes may be associated with faster weight gain after a VLCD.
引用
收藏
页码:4246 / 4250
页数:5
相关论文
共 24 条
[1]   Meta-analysis of the association of the Trp64Arg polymorphism in the β3 adrenergic receptor with body mass index [J].
Allison, DB ;
Heo, M ;
Faith, MS ;
Pietrobelli, A .
INTERNATIONAL JOURNAL OF OBESITY, 1998, 22 (06) :559-566
[2]  
BROWNELL KD, 1989, LEARN PROGRAMS LEADE, P1
[3]   Familial aggregation of obesity, candidate genes and quantitative trait loci [J].
Chagnon, YC ;
Perusse, L ;
Bouchard, C .
CURRENT OPINION IN LIPIDOLOGY, 1997, 8 (04) :205-211
[4]  
Clement K, 1996, INT J OBESITY, V20, P1062
[5]   GENETIC-VARIATION IN THE BETA(3)-ADRENERGIC RECEPTOR AND AN INCREASED CAPACITY TO GAIN WEIGHT IN PATIENTS WITH MORBID-OBESITY [J].
CLEMENT, K ;
VAISSE, C ;
MANNING, BS ;
BASDEVANT, A ;
GUYGRAND, B ;
RUIZ, J ;
SILVER, KD ;
SHULDINER, AR ;
FROGUEL, P ;
STROSBERG, AD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (06) :352-354
[6]   Assessment of fat-mass loss during weight reduction in obese women [J].
Fogelholm, GM ;
Sievanen, HT ;
Lichtenbelt, WDV ;
Westerterp, KR .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (08) :968-975
[7]   Meta-analysis of the association of Trp64Arg polymorphism of β3-adrenergic receptor gene with body mass index [J].
Fujisawa, T ;
Ikegami, H ;
Kawaguchi, Y ;
Ogihara, T .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (07) :2441-2444
[8]  
Fumeron F, 1996, INT J OBESITY, V20, P1051
[9]  
GAGNON J, 1996, J CLIN INVEST, V98, P2089
[10]   Three-year follow-up of participants in a commercial weight loss program - Can you keep it off? [J].
Grodstein, F ;
Levine, R ;
Troy, L ;
Spencer, T ;
Colditz, GA ;
Stampfer, MJ .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (12) :1302-1306